- 询价
- 2026年10月20日
15 年金牌会员
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发，品质稳、品类全，实验不再等！Takara 秋促来袭，提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ￥1200阿拉丁 22万+ 科研级产品现货速发，品质严控、科研无忧- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 库存：
大量
- 细胞形态：
其他
- 相关疾病：
其他疾病
- ATCC Number：
CRL-2397™
- 生长状态：
贴壁生长
- 运输方式：
冻存运输
- 年限：
fetus, 20 days gestation
- 物种来源：
褐鼠
- 是否是肿瘤细胞：
0
- 器官来源：
大脑
| Designations: | F98 | ||
| Depositors: | RF Barth | ||
| Biosafety Level: | 1 | ||
| Shipped: | frozen | ||
| Medium & Serum: | See Propagation | ||
| Growth Properties: | adherent | ||
| Organism: | Rattus norvegicus | ||
| Morphology: | glial |
||
| Source: | Organ: brain Disease: undifferentiated malignant glioma |
||
| Permits/Forms: | In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. | ||
| Tumorigenic: | Yes | ||
| Age: | fetus, 20 days gestation | ||
| Comments: | This tumor was produced by Drs. A. Koestner and W. Wechsler at The Ohio State University in 1971. A pregnant CD Fischer rat on day 20 of gestation was inoculated with a single dose of N-ethyl-N-nitrosourea (ENU) (50 mg/kg b.w.). Tumors were harvested and cloned. [38592 ] This cell line may be used for both in vitro and in vivo studies of a rat brain tumor. It grows well in cell culture and provides a simple, reproducible glioma model when inoculated into the brains of syngeneic rats. The biological characteristics of this tumor closely resemble those of human glioblastoma. The transplantable tumor displays an infiltrative pattern of growth within the brain. [38611 ] It is weakly immunogenic in syngeneic rats and an intracerebral inoculum of as few as 100 cells are lethal. [38613 ] The F98 and RG2 (ATCC CRL-2433 ) gliomas can be used as rat brain tumor models in experimental neuro-oncology. [39801 ] F98 was submitted to the American Type Culture Collection in June, 1998 at passage 2 from a culture established from a subcutaneous tumor grown in a male Fischer rat. |
||
| Propagation: | ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Temperature: 37.0°C |
||
| Subculturing: | Protocol:
|
||
| Preservation: | Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO Storage temperature: liquid nitrogen vapor phase |
||
| Related Products: | Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002 recommended serum:ATCC 30-2020 |
||
| References: | 38592: Ko L, et al. Morphological characterization of nitrosourea-induced glioma cell lines and clones. Acta Neuropathol. 51: 23-31, 1980. PubMed: 7435138 38606: Tzeng JJ, et al. Adoptive immunotherapy of a rat glioma using lymphokine-activated killer cells and interleukin 2. Cancer Res. 50: 4338-4343, 1990. PubMed: 2364388 38610: Barth RF, et al. Boron Neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood brain barrier disruption. Cancer Res. 57: 1129-1136, 1997. PubMed: 9067283 38611: Clendenon NR, et al. Boron neutron capture therapy of a rat glioma. Neurosurgery 26: 47-55, 1990. PubMed: 2294479 38612: Matalka KZ, et al. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent. Radiat. Res. 137: 44-51, 1994. PubMed: 8265787 38613: Tzeng JJ, et al. Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors. Cancer Res. 51: 2373-2378, 1991. PubMed: 2015600 38614: Gyngell ML, et al. Localized proton NMR spectroscopy of experimental gliomas in rat brain in vivo. NMR Biomed. 5: 335-340, 1992. PubMed: 1336973 38615: Bockhorst K, et al. Localization of experimental brain tumors in MRI by gadolinium porphyrin. Acta Neurochir. Suppl. (Wien) 60: 347-349, 1994. PubMed: 7976586 38616: Els T, et al. NMR contrast enhancement of brain tumors: Comparison of the blood brain barrier tracer GdDTPA and the tumor-selective contrast agent in MnTPPS. MAGMA 1: 126-133, 1993. 38617: Hossmann KA, et al. Regional metabolism of experimental brain tumors. Acta Neuropathol. 69: 139-147, 1986. PubMed: 3962590 38621: Eis M, et al. High resolution quantitative relaxation and diffusion MRI of three different experimental brain tumors in rat. Magn. Reson. Med. 34: 835-844, 1995. PubMed: 8598810 38622: Eis M, et al. Quantitative diffusion MR imaging of cerebral tumor and edema. Acta Neurochir. Suppl. (Wien) 60: 344-346, 1994. PubMed: 7976585 38623: Judy KD, et al. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. J. Neurosurg. 82: 481-486, 1995. PubMed: 7861228 38624: Ernestus RI, et al. Identification of intracranial liqor metastases of experimental stereotactically implanted brain tumors by the tumor-selective MRI contrast agent MnTPPS. Clin. Exp. Metastasis 10: 345-350, 1992. PubMed: 1505124 38625: Yang W, et al. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption. Int. J. Radiat. Oncol. Biol. Phys. 37: 663-672, 1997. PubMed: 9112465 38626: Yang W, et al. Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine. J. Neuro-Oncol. 33: 59-70, 1997. PubMed: 9151224 38627: Boucher Y, et al. Interstitial fluid pressure in intracranial tumours in patients and in rodents. Br. J. Cancer 75: 829-836, 1997. PubMed: 9062403 38629: Barba D, et al. Tumor immunity, immunizations and herpes simplex virus-thymidine kinase mediated tumor regression. Abstr. 1st Scientific Meeting Soc. Neuro-Onco. : 1996.. 39799: Vinores SA, Koestner A. The effect of nerve growth factor on undifferentiated glioma cells. Cancer Lett. 10: 309-318, 1980. PubMed: 7427924 39800: Kobayashi N, et al. An improved rat brain-tumor model. J. Neurosurg. 53: 808-815, 1980. PubMed: 7003068 39801: Barth RF. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J. Neuro-Oncol. 36: 91-102, 1998. PubMed: 9525831 |
||
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
询价记录
暂无询价记录
文献和实验相关实验
，在有些病例，永久性瞳孔膜淹没了过滤角，阻止眼液从过滤角通过静脉流走，眼内压升高就导致了上述症状和后遗症。 青光眼发生于WAG近交鼠群。连续兄妹交配到95代后，牛眼的发生率逐渐升高，F98代时，牛眼的发生率15.3%。 3．白内障（Cataract,ca）大鼠：病鼠出生后约14日龄眼睑睁开时，表现为晶状体混浊（常为二侧），混浊常见于晶状体的中央。病变晶状体比正常的小，呈磨茹状而不呈球状，混浊是晶状体蛋白变化的结果，而不是由于矿物质增加，视网膜可能正常，未见有任何糖尿病的迹象
9sMffkekXB4sNHvv7vvutpeWLrO//NLf2GOPL5F98YAbNRHkguTs7e23I6bPsgkHTbOZM2farKOOs23btslRRdkee2yJPfHkr23lyhX21f/2d3bHojvsTm3HHnu0Pf/i87ZixTIn8GulAb/yBz+0Y2bMsqt+8H2787bb7KQTZ9vqlSvtWRH6937g/Xb9gpusX2YhW3butKuvv86+8BeftZdfftlOPflke2HpUmnAV9nalWttZ1ePzEiY7eccWX+hKVB
技术资料暂无技术资料 索取技术资料
F98
询价
